MAPT and Alzheimer disease: Elevated levels of TMAO have been found in the cerebrospinal fluid of patients with mild cognitive impairment and AD, and are associated with pathological markers of AD including tau phosphorylation, Aβ deposition, and neurodegeneration [126].